CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapyVinodh Pillai, Susan R. Rheingold|Blood Advances|2019Cited by 201
CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P. Patel, Patrizia Porazzi, Wei Xie et al.|Science Immunology|2024Cited by 45